Tokyo gave up the previous week's strength and fell in the week ended March 19. The Nikkei 225 lost 1.6% following mixed movements, although the 17,000 mark was maintained at the close, while the Topix index dropped 2.7%. The market suffered a sharp daily setback mid-week, triggered by a tumble of New York markets with US concerns about increasing failures of subprime housing loans, but later staged a modest recovery following the rebound of US markets. Investors bought-back on the recent weakness of export-led stocks and domestic economy-based issues such as steel and machinery.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze